N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope

• Published in: Cell communication and signaling 2023-07, Vol.21 (1), p.177-177, Article 177
• Main Authors: Gregorczyk, Paulina, Porębska, Natalia, Żukowska, Dominika, Chorążewska, Aleksandra, Gędaj, Aleksandra, Malinowska, Agata, Otlewski, Jacek, Zakrzewska, Małgorzata, Opaliński, Łukasz
• Format: Article
• Language: English
• Subjects: Antibodies; Brief Report; Cancer; Cell Membrane; Cell surface; Cell surface receptors; Cells; Experiments; FGFR1; Fibroblast growth factor receptor 1; Fibroblast Growth Factors; Fibroblasts; Gene expression; Glycosylation; Growth factors; Homeostasis; Humans; Kinases; Laboratories; Localization; Mass spectrometry; Mass spectroscopy; Membrane trafficking; Mutagenesis; N-glycans; Nuclear Envelope; Nuclear transport; Nucleus; Peptides; Polysaccharides; Protein-tyrosine kinase receptors; Proteins; Receptor, Fibroblast Growth Factor, Type 1; RNA polymerase; Scientific imaging; Signal transduction; Signaling; Trafficking
• ISSN: 1478-811X; 1478-811X
• DOI: 10.1186/s12964-023-01203-3

Fibroblast growth factor receptor 1 (FGFR1) is a heavily N-glycosylated cell surface receptor tyrosine kinase that transmits signals across the plasma membrane, in response to fibroblast growth factors (FGFs). Balanced FGF/FGFR1 signaling is crucial for the development and homeostasis of the human body, and aberrant FGFR1 is frequently observed in various cancers. In addition to its predominant localization to the plasma membrane, FGFR1 has also been detected inside cells, mainly in the nuclear lumen, where it modulates gene expression. However, the exact mechanism of FGFR1 nuclear transport is still unknown. In this study, we generated a glycosylation-free mutant of FGFR1, FGFR1.GF, and demonstrated that it is localized primarily to the nuclear envelope. We show that reintroducing N-glycans into the D3 domain cannot redirect FGFR1 to the plasma membrane or exclude the receptor from the nuclear envelope. Reestablishment of D2 domain N-glycans largely inhibits FGFR1 accumulation in the nuclear envelope, but the receptor continues to accumulate inside the cell, mainly in the ER. Only the simultaneous presence of N-glycans of the D2 and D3 domains of FGFR1 promotes efficient transport of FGFR1 to the plasma membrane. We demonstrate that while disturbed FGFR1 folding results in partial FGFR1 accumulation in the ER, impaired FGFR1 secretion drives FGFR1 trafficking to the nuclear envelope. Intracellular FGFR1.GF displays a high level of autoactivation, suggesting the presence of nuclear FGFR1 signaling, which is independent of FGF. Using mass spectrometry and proximity ligation assay, we identified novel binding partners of the nuclear envelope-localized FGFR1, providing insights into its cellular functions. Collectively, our data define N-glycosylation of FGFR1 as an important regulator of FGFR1 kinase activity and, most importantly, as a switchable signal for FGFR1 trafficking between the nuclear envelope and plasma membrane, which, due to spatial restrictions, shapes FGFR1 interactome and cellular function. Video Abstract.